Skip to Content Facebook Feature Image

THIRDREALITY CES 2026 Recap: Real Stories, Real Homes, and What Comes Next

Business

THIRDREALITY CES 2026 Recap: Real Stories, Real Homes, and What Comes Next
Business

Business

THIRDREALITY CES 2026 Recap: Real Stories, Real Homes, and What Comes Next

2026-01-16 23:00 Last Updated At:23:15

SAN JOSE, Calif., Jan. 16, 2026 /PRNewswire/ -- CES is always about what's new. But for THIRDREALITY, CES 2026 became something more meaningful: a moment to listen, reflect, and see how technology built around real-life needs is already shaping everyday homes.

Throughout the week, our booth welcomed partners, integrators, creators, and long-time users from around the world. They didn't just ask about product specifications—they shared stories. And those stories reminded us why we build.

When Smart Technology Fits Real Homes

One of the most frequently discussed products at our booth was the Smart Garage Door Opener, built on Matter over Wi-Fi and designed to work with existing garage remotes.

A visitor told us how seamlessly it fit into their daily routine:

"I didn't have to replace anything or change my setup. I just added the device, and now I can check and control my garage door remotely with total confidence. It's simple, and it just works."

Another conversation stayed with us even longer. A long-time customer described how our Smart Switch helped transform their 1970s home into a modern smart living space—without rewiring or major renovation.

"My house was never designed for smart devices," they said. "But your switch made it possible. It gave my old home a second life."

For us, these moments captured the heart of what THIRDREALITY stands for:
Smart technology should adapt to real homes, real people, and real constraints.

Product Focus: Plant Care, Presence Sensing, and Smart Blinds

While THIRDREALITY presented a broad range of smart home devices at CES 2026, several product areas in particular generated consistent attention at the booth.

The Smart Soil Moisture Sensor Gen 2 was presented as part of a broader plant care solution, working alongside the company's smart watering system. Visitors asked about updates based on user feedback, including improvements aimed at measurement consistency and long-term durability. In addition to indoor plants and balcony gardens, many attendees also discussed outdoor use cases such as small yards and garden beds. Questions frequently focused on wireless coverage in outdoor environments, with interest in how THIRDREALITY's own Zigbee repeater can be used to extend network range and support reliable data transmission for soil monitoring and automated watering in these settings.

Presence sensing was another frequently discussed topic, particularly across two radar-based products using 60GHz and 24GHz technologies. The 60GHz radar presence sensor is powered via USB-C for always-on applications, while the 24GHz version operates on three AA batteries to support flexible, wire-free placement. Both sensors offer adjustable sensitivity, allowing detection ranges to be tuned for different room sizes and use cases. Attendees asked about applications in bedrooms, kitchen, and workspaces, where precise presence detection can enable more responsive and context-aware automation than traditional motion sensors.

The company's Smart Blind Gen2 also drew strong interest. Many visitors commented on the design of the battery module positioned at the bottom, which simplifies access for charging. The blind uses a Type-C rechargeable battery and supports custom sizing, with widths up to 80 inches and heights up to 74 inches. Discussions at the booth focused on ease of installation, maintenance convenience, and how the design fits into everyday living spaces.

As we move into 2026

THIRDREALITY will continue developing across both Zigbee and Matter platforms, with a strong focus on Matter over Thread—bringing faster response, lower power consumption, and more resilient mesh networking to future devices.

To every customer who shared their story, every partner who stopped by, and every friend we reconnected with: thank you. Your feedback, trust, and support continue to shape what we build.

CES 2026 reminded us that innovation is not just about what's next—it's about what already matters to people today. We'll see you again next year, right here in Las Vegas.

About THIRDREALITY

Third Reality is a smart home technology company, dedicated to developing high-quality, user-friendly, and secure smart home products. Through continuous innovation and a deep understanding of market needs, the company strives to provide an improved smart home experience for users worldwide.

Related Links:

Twitter | Instagram | Facebook | YouTube | TikTok

 

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

THIRDREALITY CES 2026 Recap: Real Stories, Real Homes, and What Comes Next

THIRDREALITY CES 2026 Recap: Real Stories, Real Homes, and What Comes Next

The National University Centre for Digestive Health heralds a new era of care through quicker cross-referrals to surgical specialties, strengthened community partnerships and patient-friendly treatment delivery

SINGAPORE, Jan. 16, 2026 /PRNewswire/ -- Digestive health is central to overall well-being, influencing nutrition, immunity, and quality of life. Yet common conditions, such as ulcers, liver disease, and colorectal disorders, often go undetected until they lead to serious complications. To address this, the National University Hospital (NUH) has officially opened the National University Centre for Digestive Health (NUCD), a facility dedicated to early detection, advanced treatment, and seamless patient care for digestive diseases.

Since its concept launch in 2024, NUCD has focused on consolidating NUH's digestive health services under one roof to provide greater convenience for patients. Its reach extends beyond NUH, serving as a referral hub for complex cases from other hospitals within the National University Health System, including Ng Teng Fong General Hospital and Alexandra Hospital, ensuring patients receive specialised care when needed.

With its official opening, the Centre is strengthening the entire care pathway by accelerating access from initial digestive consultation to surgical expertise in Upper Gastrointestinal, Hepatobiliary and Pancreatic, and Colorectal, so patients can see the right specialists on the same day. This streamlined approach reduces waiting times, minimises repeated visits, and enables faster treatment decisions for better outcomes.

Strengthening prevention: From community collaborations to clinical excellence

NUCD has contributed significantly to the clinical validation and implementation of the Fibrosis-4 (FIB-4) score and fibroscan to screen for liver fibrosis, or scarring of the liver, in high-risk patients with fatty liver and other chronic liver diseases[1]. Since September 2022, a chronic liver disease screening programme for high-risk individuals has been launched in partnership with National University Polyclinics and General Practitioners (GP) clinics. Through consultations and routine health assessments done at these clinics, asymptomatic individuals identified as potentially high-risk are referred to NUCD for comprehensive screening. To date, the Centre has screened more than 12,000 high-risk patients, facilitating earlier detection and interventions. With continuing medical education and engagement, NUCD continues to expand this network to enhance preventive care for liver health.

Another key focus of the Centre is improving the detection of colorectal cancer, often called a 'silent killer' because symptoms usually appear only in later stages. According to the Singapore Cancer Registry Annual Report 2022[2], colorectal cancer is the second most common cancer and the second leading cause of cancer-related deaths locally. To tackle this, the Centre is improving colonoscopy quality by increasing the Adenoma Detection Rate (ADR), a measure of how often doctors detect and remove precancerous polyps during the procedure.

Studies[3] show that every 1 per cent increase in ADR lowers colorectal cancer risk by 3 per cent, making these improvements a vital step in prevention. Put simply, a higher ADR means that more polyps are removed early, reducing cancer risk. New initiatives such as AI-enabled and image-enhanced colonoscopy, an automated ADR calculation system, and a dashboard displaying critical quality indicators for endoscopists have helped boost ADR at NUCD from 33.5 per cent in 2022 to 42.4 per cent in 2025, well above the American Society for Gastrointestinal Endoscopy guideline of at least 25 per cent[4].

Making IBD care more convenient and precise

Established in 2016, the Inflammatory Bowel Disease (IBD) Centre of Excellence is now a cornerstone of NUCD, delivering advanced care across all ages - from paediatric to adult patients. Among its key innovations is the home administration of intravenous biologics, reducing the need for frequent hospital visits and improving convenience.

Others include point-of-care intestinal ultrasound, which enables real-time, non-invasive assessment during clinic consultations, and a translational precision medicine programme that personalises treatment and provides access to clinical trials and novel therapies, such as faecal microbiota transplantation. The IBD Centre of Excellence also aims to play a leading role in regional education, having hosted IBD training programmes for over 100 healthcare professionals from ASEAN countries in the past five years.

"The launch of NUCD marks a significant step forward in how we care for patients with digestive conditions," said Adj A/Prof Lee Guan Huei, Centre Director, National University Centre for Digestive Health. "By bringing together advanced diagnostics, specialist expertise, and cutting-edge technology, we aim to deliver care that is faster, more precise, and patient-focused. At the same time, we are driving research into new detection methods and innovative therapies, such as blood-based diagnostic tools that reduce the need for invasive procedures while maintaining accuracy. Our goal is simple - to detect problems early, treat them well, and help our patients live healthier lives." Adj A/Prof Lee is also Head and Senior Consultant, Division of Gastroenterology and Hepatology, Department of Medicine, NUH.

About the National University Hospital (NUH)

­­The National University Hospital (NUH) is Singapore's leading university hospital. While the hospital at Kent Ridge first received its patients on 24 June 1985, our legacy started from 1905, the date of the founding of what is today the NUS Yong Loo Lin School of Medicine. NUH is the principal teaching hospital of the medical school.

Our unique identity as a university hospital is a key attraction for healthcare professionals who aspire to do more than practise tertiary medical care. We offer an environment where research and teaching are an integral part of medicine, and continue to shape medicine and transform care for the community we care for.

We are an academic medical centre with over 1,200 beds, serving more than one million patients a year with over 50 medical, surgical and dental specialties. NUH is the only public and not-for-profit hospital in Singapore to provide trusted care for adults, women and children under one roof, including the only paediatric kidney and liver transplant programme in the country.

The NUH is a key member of the National University Health System (NUHS), one of three public healthcare clusters in Singapore. For more information, visit www.nuh.com.sg

Follow us on

Facebook | Instagram | LinkedIn | TikTok | YouTube

[1] Chew NWS, Ng CH, Chan KE, et al. FIB-4 Predicts MACE and Cardiovascular Mortality in Patients With Nonalcoholic Fatty Liver Disease. Can J Cardiol 2022 Nov;38(11):1779-1780.

[2] Singapore Cancer Registry Annual Report 2022, September 2024, https://www.nrdo.gov.sg/publications/cancer 

[3] Corley DA, Levin TR, Doubeni CA.Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014;370:2541.

[4] Song YM, Han KS, Kim BC, Hong CW, Kim B, Kim MC, Jin MJ, Sohn DK. Analysis of adenoma detection rate of colonoscopy among trainees. Ann Coloproctol. 2024 Dec;40(6):548-554. doi: 10.3393/ac.2023.00199.0028. Epub 2024 Aug 28. PMID: 39191316; PMCID: PMC11701454.



The National University Centre for Digestive Health heralds a new era of care through quicker cross-referrals to surgical specialties, strengthened community partnerships and patient-friendly treatment delivery

SINGAPORE, Jan. 16, 2026 /PRNewswire/ -- Digestive health is central to overall well-being, influencing nutrition, immunity, and quality of life. Yet common conditions, such as ulcers, liver disease, and colorectal disorders, often go undetected until they lead to serious complications. To address this, the National University Hospital (NUH) has officially opened the National University Centre for Digestive Health (NUCD), a facility dedicated to early detection, advanced treatment, and seamless patient care for digestive diseases.

Since its concept launch in 2024, NUCD has focused on consolidating NUH's digestive health services under one roof to provide greater convenience for patients. Its reach extends beyond NUH, serving as a referral hub for complex cases from other hospitals within the National University Health System, including Ng Teng Fong General Hospital and Alexandra Hospital, ensuring patients receive specialised care when needed.

With its official opening, the Centre is strengthening the entire care pathway by accelerating access from initial digestive consultation to surgical expertise in Upper Gastrointestinal, Hepatobiliary and Pancreatic, and Colorectal, so patients can see the right specialists on the same day. This streamlined approach reduces waiting times, minimises repeated visits, and enables faster treatment decisions for better outcomes.

Strengthening prevention: From community collaborations to clinical excellence

NUCD has contributed significantly to the clinical validation and implementation of the Fibrosis-4 (FIB-4) score and fibroscan to screen for liver fibrosis, or scarring of the liver, in high-risk patients with fatty liver and other chronic liver diseases[1]. Since September 2022, a chronic liver disease screening programme for high-risk individuals has been launched in partnership with National University Polyclinics and General Practitioners (GP) clinics. Through consultations and routine health assessments done at these clinics, asymptomatic individuals identified as potentially high-risk are referred to NUCD for comprehensive screening. To date, the Centre has screened more than 12,000 high-risk patients, facilitating earlier detection and interventions. With continuing medical education and engagement, NUCD continues to expand this network to enhance preventive care for liver health.

Another key focus of the Centre is improving the detection of colorectal cancer, often called a 'silent killer' because symptoms usually appear only in later stages. According to the Singapore Cancer Registry Annual Report 2022[2], colorectal cancer is the second most common cancer and the second leading cause of cancer-related deaths locally. To tackle this, the Centre is improving colonoscopy quality by increasing the Adenoma Detection Rate (ADR), a measure of how often doctors detect and remove precancerous polyps during the procedure.

Studies[3] show that every 1 per cent increase in ADR lowers colorectal cancer risk by 3 per cent, making these improvements a vital step in prevention. Put simply, a higher ADR means that more polyps are removed early, reducing cancer risk. New initiatives such as AI-enabled and image-enhanced colonoscopy, an automated ADR calculation system, and a dashboard displaying critical quality indicators for endoscopists have helped boost ADR at NUCD from 33.5 per cent in 2022 to 42.4 per cent in 2025, well above the American Society for Gastrointestinal Endoscopy guideline of at least 25 per cent[4].

Making IBD care more convenient and precise

Established in 2016, the Inflammatory Bowel Disease (IBD) Centre of Excellence is now a cornerstone of NUCD, delivering advanced care across all ages - from paediatric to adult patients. Among its key innovations is the home administration of intravenous biologics, reducing the need for frequent hospital visits and improving convenience.

Others include point-of-care intestinal ultrasound, which enables real-time, non-invasive assessment during clinic consultations, and a translational precision medicine programme that personalises treatment and provides access to clinical trials and novel therapies, such as faecal microbiota transplantation. The IBD Centre of Excellence also aims to play a leading role in regional education, having hosted IBD training programmes for over 100 healthcare professionals from ASEAN countries in the past five years.

"The launch of NUCD marks a significant step forward in how we care for patients with digestive conditions," said Adj A/Prof Lee Guan Huei, Centre Director, National University Centre for Digestive Health. "By bringing together advanced diagnostics, specialist expertise, and cutting-edge technology, we aim to deliver care that is faster, more precise, and patient-focused. At the same time, we are driving research into new detection methods and innovative therapies, such as blood-based diagnostic tools that reduce the need for invasive procedures while maintaining accuracy. Our goal is simple - to detect problems early, treat them well, and help our patients live healthier lives." Adj A/Prof Lee is also Head and Senior Consultant, Division of Gastroenterology and Hepatology, Department of Medicine, NUH.

About the National University Hospital (NUH)

­­The National University Hospital (NUH) is Singapore's leading university hospital. While the hospital at Kent Ridge first received its patients on 24 June 1985, our legacy started from 1905, the date of the founding of what is today the NUS Yong Loo Lin School of Medicine. NUH is the principal teaching hospital of the medical school.

Our unique identity as a university hospital is a key attraction for healthcare professionals who aspire to do more than practise tertiary medical care. We offer an environment where research and teaching are an integral part of medicine, and continue to shape medicine and transform care for the community we care for.

We are an academic medical centre with over 1,200 beds, serving more than one million patients a year with over 50 medical, surgical and dental specialties. NUH is the only public and not-for-profit hospital in Singapore to provide trusted care for adults, women and children under one roof, including the only paediatric kidney and liver transplant programme in the country.

The NUH is a key member of the National University Health System (NUHS), one of three public healthcare clusters in Singapore. For more information, visit www.nuh.com.sg

Follow us on

Facebook | Instagram | LinkedIn | TikTok | YouTube

[1] Chew NWS, Ng CH, Chan KE, et al. FIB-4 Predicts MACE and Cardiovascular Mortality in Patients With Nonalcoholic Fatty Liver Disease. Can J Cardiol 2022 Nov;38(11):1779-1780.

[2] Singapore Cancer Registry Annual Report 2022, September 2024, https://www.nrdo.gov.sg/publications/cancer 

[3] Corley DA, Levin TR, Doubeni CA.Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014;370:2541.

[4] Song YM, Han KS, Kim BC, Hong CW, Kim B, Kim MC, Jin MJ, Sohn DK. Analysis of adenoma detection rate of colonoscopy among trainees. Ann Coloproctol. 2024 Dec;40(6):548-554. doi: 10.3393/ac.2023.00199.0028. Epub 2024 Aug 28. PMID: 39191316; PMCID: PMC11701454.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

NUH INAUGURATES NEW CENTRE TO ADVANCE PREDICTIVE AND ACCESSIBLE CARE FOR DIGESTIVE HEALTH

NUH INAUGURATES NEW CENTRE TO ADVANCE PREDICTIVE AND ACCESSIBLE CARE FOR DIGESTIVE HEALTH

Recommended Articles